MTOR and neoplasm: According to experiments in A/J mice, the combined use of CCM and salsalate more effectively inhibits activation of the PI3K/Akt/mTOR pathway, attenuates the abnormal proliferation of colonic mucosa, and reduces tumor proliferation, whereas CCM or salsalate alone do not inhibit abnormal crypt cell proliferation or tumor multiplicity (82).